MERGERS & ACQUSITIONS

17 minute read

Jul. 12, 2024

Drug Hunter 2023 M&A Review: Part 4 - Biologics-Focused Deals

Author:

Oliver Philps

Reviewer:

Lew Pennington

Editor:

Other articles you may be interested in